| Prognostic factors in 1038 women with metastatic breast cancer R Largillier, JM Ferrero, J Doyen, J Barriere, M Namer, V Mari, A Courdi, ... Annals of Oncology 19 (12), 2012-2019, 2008 | 435 | 2008 |
| MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines S Grosso, J Doyen, SK Parks, T Bertero, A Paye, B Cardinaud, P Gounon, ... Cell death & disease 4 (3), e544-e544, 2013 | 248 | 2013 |
| Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome J Doyen, C Trastour, F Ettore, I Peyrottes, N Toussant, J Gal, K Ilc, D Roux, ... Biochemical and biophysical research communications 451 (1), 54-61, 2014 | 117 | 2014 |
| Aromatase inhibition in male breast cancer patients: biological and clinical implications J Doyen, A Italiano, R Largillier, JM Ferrero, X Fontana, A Thyss Annals of Oncology 21 (6), 1243-1245, 2010 | 114 | 2010 |
| Aromatase inhibition in male breast cancer patients: biological and clinical implications J Doyen, A Italiano, R Largillier, JM Ferrero, X Fontana, A Thyss Annals of Oncology 21 (6), 1243-1245, 2010 | 114 | 2010 |
| Proton beams in cancer treatments: clinical outcomes and dosimetric comparisons with photon therapy J Doyen, AT Falk, V Floquet, J Hérault, JM Hannoun-Lévi Cancer treatment reviews 43, 104-112, 2016 | 106 | 2016 |
| Circulating tumor cells in prostate cancer: a potential surrogate marker of survival J Doyen, C Alix-Panabieres, P Hofman, SK Parks, E Chamorey, H Naman, ... Critical reviews in oncology/hematology 81 (3), 241-256, 2012 | 91 | 2012 |
| A diagnostic biopsy-adapted immunoscore predicts response to neoadjuvant treatment and selects patients with rectal cancer eligible for a watch-and-wait strategy C El Sissy, A Kirilovsky, M Van den Eynde, AM Muşină, MG Anitei, ... Clinical Cancer Research 26 (19), 5198-5207, 2020 | 84 | 2020 |
| Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer D Azria, J Doyen, M Jarlier, I Martel-Lafay, C Hennequin, P Etienne, ... Annals of Oncology 28 (10), 2436-2442, 2017 | 84 | 2017 |
| Expression of a truncated active form of VDAC1 in lung cancer associates with hypoxic cell survival and correlates with progression to chemotherapy resistance MC Brahimi-Horn, D Ben-Hail, M Ilie, P Gounon, M Rouleau, V Hofman, ... Cancer research 72 (8), 2140-2150, 2012 | 82 | 2012 |
| Knock-down of hypoxia-induced carbonic anhydrases IX and XII radiosensitizes tumor cells by increasing intracellular acidosis J Doyen, SK Parks, S Marcié, J Pouysségur, J Chiche Frontiers in oncology 2, 199, 2013 | 79 | 2013 |
| Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study JP Gérard, N Barbet, J Gal, C Dejean, L Evesque, J Doyen, R Coquard, ... European Journal of Cancer 108, 1-16, 2019 | 64 | 2019 |
| Brachytherapy versus external beam radiotherapy boost for prostate cancer: Systematic review with meta-analysis of randomized trials DLC Kee, J Gal, AT Falk, R Schiappa, ME Chand, M Gautier, J Doyen, ... Cancer treatment reviews 70, 265-271, 2018 | 53 | 2018 |
| Effects of proton versus photon irradiation on (lymph) angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinoma M Lupu-Plesu, A Claren, S Martial, PD N'diaye, K Lebrigand, N Pons, ... Oncogenesis 6 (7), e354-e354, 2017 | 49 | 2017 |
| Patterns of proton therapy use in pediatric cancer management in 2016: an international survey N Journy, DJ Indelicato, DR Withrow, T Akimoto, C Alapetite, M Araya, ... Radiotherapy and Oncology 132, 155-161, 2019 | 48 | 2019 |
| Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients AC Frin, L Evesque, J Gal, K Benezery, E François, J Gugenheim, ... European Journal of Cancer 72, 124-136, 2017 | 44 | 2017 |
| Metformin for non-small cell lung cancer patients: Opportunities and pitfalls A Levy, J Doyen Critical reviews in oncology/hematology 125, 41-47, 2018 | 42 | 2018 |
| Organ preservation in rectal adenocarcinoma (T1) T2-T3 Nx M0. Historical overview of the Lyon Sud–Nice experience using contact x-ray brachytherapy and external beam … JP Gerard, AC Frin, J Doyen, FX Zhou, J Gal, P Romestaing, N Barbet, ... Acta Oncologica 54 (4), 550-556, 2015 | 40 | 2015 |
| EGFR, KRAS, BRAF, and HER‐2 molecular status in brain metastases from 77 NSCLC patients C Villalva, V Duranton‐Tanneur, K Guilloteau, F Burel‐Vandenbos, ... Cancer medicine 2 (3), 296-304, 2013 | 40 | 2013 |
| Radiosensitivity of colon and rectal lung oligometastasis treated with stereotactic ablative radiotherapy R Kinj, PY Bondiau, E François, JP Gérard, AO Naghavi, A Leysalle, ... Clinical colorectal cancer 16 (3), e211-e220, 2017 | 36 | 2017 |
